Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Nitric Oxide Gas Inhalation Therapy for Mechanically Ventilated Patients With Severe Acute Respiratory Syndrome Caused by SARS-CoV2: a Randomized Clinical Trial.

NCT04306393 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT04306393
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04306393 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Nitric Oxide Gas Inhalation Therapy for Mechanically Ventilated Patients With Severe Acute Respiratory Syndrome Caused by SARS-CoV2: a Randomized Clinical Trial.
Lead sponsor
Massachusetts General Hospital
Phase
Phase 2
Overall status
Completed
Start date
March 21, 2020
Completion date
June 15, 2022
Enrollment
200 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

coronavirus, sars (severe acute respiratory syndrome)